Recurrent Neuroleptic Malignant Syndrome: A Case Report

dc.contributor.authorAşkın, R.
dc.contributor.authorHerken, H.
dc.contributor.authorDerman, H.
dc.date.accessioned2020-03-26T16:36:28Z
dc.date.available2020-03-26T16:36:28Z
dc.date.issued2000
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractBackground: Neuroleptic malignant syndrome (NMS) is an uncommon, but serious complication of antipsychotic drug treatment that is characterized by muscular rigidity, hyperthermia, altered state of consciousness and autonomic dysfunction. Design: A case of NMS that is characterized by recurrence due to patient's negligence during haloperidol treatment is reported. Aim: To discuss the management of recurrent NMS and choices of post-NMS treatment in the light of the literature. Conclusion: The culprit drug should be changed immediately after the diagnosis of NMS. An atypical antipsychotic drug would be the choice of treatment of psychotic symptoms.en_US
dc.identifier.citationAşkın, R., Herken, H., Derman, H., (2000). Recurrent Neuroleptic Malignant Syndrome: A Case Report. International Medical Journal, 7(4), 287-288.
dc.identifier.endpage288en_US
dc.identifier.issn1341-2051en_US
dc.identifier.issue4en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage287en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12395/17318
dc.identifier.volume7en_US
dc.indekslendigikaynakScopusen_US
dc.institutionauthorAşkın, R.
dc.institutionauthorHerken, H.
dc.institutionauthorDerman, H.
dc.language.isoenen_US
dc.relation.ispartofInternational Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectHaloperidolen_US
dc.subjectNeuroleptic malignant syndromeen_US
dc.subjectRecurrenceen_US
dc.titleRecurrent Neuroleptic Malignant Syndrome: A Case Reporten_US
dc.typeArticleen_US

Dosyalar